Moreover, we have tested niclosamide in vitro in ALS fibroblasts and in vivo in a transgenic mouse model of ALS overexpressing human FUS (hFUS), recapitulating pathological features of the disease, to understand its potential efficacy in ameliorating ALS pathology. Here, FUS is linked to amyotrophic lateral sclerosis.